Arcus Biosciences Other Operating Expenses (Quarterly) Analysis

Arcus Biosciences, Inc. (RCUS)

24.56 +1.82 (+8.00%) USD | NYSE | Jan 14, 16:00

24.30 -0.26 (-1.06%) Pre-Market: 20:00

View Other Operating Expenses (Quarterly) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	--
Actinium Pharmaceuticals, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
Karyopharm Therapeutics, Inc.	--
Janux Therapeutics, Inc.	--